Heat-Activated Probiotic Composition for Gut Inflammation Reduction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current probiotics fail to effectively germinate and activate in the harsh gastric environment, leading to inadequate treatment of inflammatory bowel diseases like ulcerative colitis and Crohn's disease, as most spores die before reaching the intestines where inflammation occurs.
Innovation Solution
A probiotic composition comprising Bacillus spores and a nutrient germinant composition that can be heat-activated before consumption, allowing for rapid germination in the intestinal tract, reducing inflammation by providing active bacteria at the site of inflammation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional probiotics are consumed, then they are intended to reach the intestine to exert health benefits, but most probiotic bacteria die in the harsh gastric environment before reaching the intestine
Solution Approach 1:
The patent applies preliminary action by pre-germinating Bacillus spores in a germination buffer before consumption. This activates the spores in advance, transforming them from dormant to vegetative state, so they can immediately colonize the intestine upon arrival, bypassing the need to survive gastric conditions in vulnerable form. The spores are activated in a controlled environment before exposure to the harsh gastric milieu.
Solution Approach 2:
The patent utilizes parameter changes by transforming the physical state of Bacillus from dormant spores to active vegetative cells through controlled germination conditions (temperature, pH, nutrient availability). This parameter transformation occurs in the germination buffer before consumption, ensuring the bacteria arrive in the intestine in an active, functional state rather than dormant spore form.
2Speed
If probiotics are heated to activate spores, then germination is accelerated, but excessive heat may kill the bacteria
Solution Approach 1:
The patent applies parameter changes by using controlled temperature ranges (37-42°C or room temperature) during germination that are sufficient to activate spores but below thresholds that would kill bacteria. This optimized temperature parameter, combined with appropriate pH and nutrient conditions in the germination buffer, achieves rapid germination while preserving bacterial viability for subsequent intestinal colonization.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The solution enables a significant reduction in intestinal inflammation, as indicated by a decrease in C-reactive protein levels, with the probiotic composition effectively germinating and becoming active in the small intestine to alleviate symptoms of inflammatory bowel diseases.
Implementation Method 1
The addition of heat, such as that in a hot beverage (tea, coffee, etc.) or human body temperature (approx. 37° C.) speeds this step up.
Implementation Method 2
Germination is a complex process in which spores are revived from the dormant state so they may develop into a fully vegetative growth state.
Data Source
AI summary
A probiotic composition and method for activating probiotic spores for consumption by a human to reduce inflammation in or treat inflammatory conditions in the gut. A probiotic composition comprises a nutrient-germinant composition, one or more species of Bacillus spores, and optionally a food or beverage product, which are mixed or pre-mixed in any combination. A nutrient-germinant composition comprises one or more L-amino acids, optionally a source of potassium ions, and optionally one or more buffers, if the source of potassium ions is not also a buffer. A method of activating the spores comprises heating the probiotic composition or food or beverage containing the probiotic composition to a temperature range of around 42° C.-100° C., more preferably 70° C.-85° C. prior to being administered to ingested. Dosing the probiotic composition at around 1 to 4 grams per day over a treatment cycle can reduce indicators of inflammation by at least 10-20% or more.